Verogen partners with QIAGEN to provide innovative solutions for human identification laboratories
SAN DIEGO & HILDEN, Germany & GERMAN CITY, Maryland – (COMMERCIAL THREAD) – QIAGEN NV (NYSE: QGEN) (Frankfurt Prime Standard: QIA) and Verogen Inc. today announced a partnership to provide laboratories with superior tools and comprehensive support for the implementation of workflows. Human Identification Next Generation Sequencing (NGS).
The partnership with QIAGEN is a milestone-based distribution and development agreement that grants QIAGEN the rights to distribute current and future Verogen products globally. Verogen and QIAGEN will also collaborate to commercialize Verogen’s forensic validated NGS workflows with QIAGEN’s sample preparation automation to provide complete ID sample solutions for human identification laboratories.
âOur mission is to equip the human identification community with innovative tools capable of providing identification, not just a DNA profile,â said Brett Williams, CEO of Verogen. âThis partnership with QIAGEN will make it easier for laboratories to provide more impactful responses. By combining Verogen’s industry-leading NGS product portfolio with QIAGEN’s benchmark extraction, analysis and automation solutions, we can accelerate the adoption and use of NGS in forensic operations â. âThis combination brings together Verogen’s innovative NGS workflows with QIAGEN’s leading portfolio of Sample to Insight solutions, creating the most comprehensive product offering for forensic applications,â said Thierry Bernard, CEO of QIAGEN . âThe partnership will drive the adoption of NGS in human identification, as it will allow our clients to gain even better information from their sample records. This will ultimately strengthen legal systems around the world. ”
Verogen’s turnkey solutions for human identification laboratories combine state-of-the-art NGS sequencing instrumentation, proprietary library preparation reagents and sequencing consumables with sophisticated application-specific software. Through this partnership, QIAGEN will optimize its sample extraction and library preparation automation capabilities for the Verogen ForenSeq.Â® Library prep kits, improving the reach and presence of both companies’ channels to support the forensic market.
Verogen is a dedicated developer of DNA-based biometric human identification products for the analysis of forensic genomic samples. Working closely with the forensic community, Verogen places exceptional value on flexible and scalable solutions that deliver reliable results. To learn more, visit www.verogen.com
QIAGEN NV, a Netherlands-based holding company, is the world’s leading supplier of Sample at Insight solutions that enable customers to gain valuable molecular information from samples containing the building blocks of life. QIAGEN provides solutions to more than 500,000 customers worldwide in the fields of molecular diagnostics (human health) and life sciences (universities, pharmaceutical R&D and industrial applications, mainly forensics). More information is available at http://www.qiagen.com.